MDxHealth (MDXH) Other financing activities (2023 - 2024)

MDxHealth has reported Other financing activities for 3 years, with the latest figure at -$344000.0 in Q3 2025.

• Quarterly Other financing activities fell 100.92% year-over-year to -$344000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $40.3 million (up 7.93% YoY) and the FY2025 annual result came in at $22.3 million, changed N/A from the prior year.
• Other financing activities slipped to -$344000.0 in Q3 2025 per MDXH's latest filing, from -$227000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $40.2 million in Q4 2021 and troughed at -$344000.0 in Q3 2025.
• A 3-year average of $16.1 million and a median of $3.5 million in 2024 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 100.92% in 2025, down 100.92% in 2025.
• Over 3 years, Other financing activities stood at $40.2 million in 2021, then tumbled by 91.22% to $3.5 million in 2024, then sank by 109.74% to -$344000.0 in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered -$344000.0, -$227000.0, and $3.5 million for Q3 2025, Q2 2025, and Q4 2024 respectively.